Articles related to STATINS

Physicians should be aware of the evolving research regarding statins and dementia. Recent studies provide mixed evidence, with some suggesting a potential protective effect of statins against dementia, underscoring the necessity for individualized patient assessments.

In a significant shift, recent findings indicate that statins, specifically simvastatin, may play a crucial role in enhancing cognitive function in dementia patients, challenging the traditional perception of their use.

Emerging research suggests that statins, while beneficial in some respects, could potentially exacerbate coronary artery calcification and deplete vital heart-protecting nutrients.

The recent LODESTAR clinical trial has revealed that although the two statins are equally effective in preventing heart attacks, strokes, and death, one has been associated with a higher risk of developing type 2 diabetes and requiring cataract surgery.

A recent study involving 4,400 participants revealed that two major statins—rosuvastatin and atorvastatin—are equally effective at reducing heart attacks, strokes, and all-cause deaths. However, it was found that the rosuvastatin group was more likely (7.2%) to develop type 2 diabetes than the atorvastatin group (5.3%).

This study provides valuable insights into the comparative benefits and risks of rosuvastatin and atorvastatin in adults with coronary artery disease. Notably, while both drugs showed comparable efficacy, rosuvastatin was associated with a higher risk of new onset diabetes mellitus and cataract surgery.